Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Experimental & Molecular Medicine ; : e74-2014.
Article in English | WPRIM | ID: wpr-36643

ABSTRACT

Dendritic cells (DCs), which are regarded as the most potent antigen-presenting cells, are involved in innate and adaptive immunity. Upon uptake of pathogens, DCs express cell surface markers and secrete cytokines. In this study, we analyzed production of cytokines and found that interleukin (IL)-10 and transforming growth factor (TGF)-beta production significantly increased in bone marrow-derived DCs and a mouse DC line, DC2.4, after treatment with crude antigen (CA) from liver fluke, Clonorchis sinensis. However, expression patterns of several activation molecules did not change. In addition, following treatment of DC2.4 cells with antigen from the lung fluke, Paragonimus westermani, production of IL-10 and TGF-beta significantly increased compared with groups treated with other parasite antigens, Spirometra erinacei plerocercoid CA and Echinococcus granulosus hydatid cystic fluid. We also found that treatment of DC2.4 cells with C. sinensis CA resulted in rapid and significant phosphorylation of extracellular signal-regulated kinase 1/2, a mitogen-activated protein kinase. Following treatment of DC2.4 cells with C. sinensis CA, treatment with an inhibitor specific to an extracellular signal-regulated kinase inhibited production of IL-10 and TGF-beta. Our results suggest that CA from C. sinensis has a role in the anti-inflammatory function of DC cells by inducing IL-10 and TGF-beta through activation of extracellular signal-regulated kinase 1/2.


Subject(s)
Animals , Mice , Antigens, Helminth/pharmacology , Cells, Cultured , Clonorchis sinensis/immunology , Dendritic Cells/drug effects , Interleukin-10/genetics , MAP Kinase Signaling System , Transforming Growth Factor beta/genetics
2.
Rev. ciênc. farm. básica apl ; 28(2): 209-214, 2007. tab
Article in Portuguese | LILACS | ID: lil-486512

ABSTRACT

A esquistossomose mansônica é causada pelo trematódeo digenético intravascular Schistosoma mansoni. Para o tratamento dessa enfermidade o praziquantel (PZQ) e a oxamniquina (OXA) são os fármacos escolhidos. Noentanto, esses fármacos apresentam limitações quanto à ação e casos de resistência ou tolerância já foram relatados. Por esse motivo, são necessários os estudos de novas alternativas que visam melhorar os fármacos já existentes, como a incorporação desses em lipossomas. Este estudo verificou a ação do praziquantel incorporado a lipossomas (lip.PZQ) sobre os ovos de S. mansoni, linhagem BH em camundongos Mus musculus (Swiss-SPF). Para tanto, foram testadas quatro doses de PZQ elip.PZQ (47; 60; 250 e 300mg/kg) sendo que parte dos camundongos foi tratada após 30 dias de infecção e outra após 45 dias. A análise do o ograma mostrou que a dose lip.PZQ 300mg/kg administrada no 45º dia de infecção foi mais eficaz, pois reduziu a oviposição pelas fêmeas de S. mansoni.


Subject(s)
Animals , Mice , Anthelmintics/therapeutic use , Antigens, Helminth/pharmacology , Praziquantel/pharmacology , Schistosoma mansoni , Liposomes
3.
Braz. j. med. biol. res ; 32(11): 1429-36, Nov. 1999. graf, tab
Article in English | LILACS | ID: lil-248437

ABSTRACT

Injection of an Ascaris suum extract (Asc) affects both the humoral and cellular immune responses to unrelated antigens when it is co-administered with these antigens. In the present study we evaluated the effect of Asc on macrophage activation in the early phase of Mycobacterium bovis BCG (Pasteur strain TMCC 1173) infection in C57Bl/6 mice. C57Bl/6 mice were injected intraperitoneally (ip) with 0.1 mg BCG (BCG group) or BCG plus 1 mg Asc (BCG + Asc group). The peritoneal exudates were obtained at 2, 7 and 14 days after infection. The numbers of IFN-g-secreting cells were assessed by the ELISPOT assay. Nitric oxide (NO) production was measured by the Griess method and by the evaluation of NADPH diaphorase activity in the peritoneal exudates. The administration of Asc extract increased NADPH diaphorase activity (2 days: control = 0, BCG = 7 per cent, BCG + Asc = 13 per cent, and Asc = 4 per cent; 7 days: control = 4, BCG = 13 per cent, BCG + Asc = 21 per cent, and Asc = 4.5 per cent) and TNF-a levels (mean + or - SD; 2 days: control = 0, BCG = 169 + or - 13, BCG + Asc = 202 + or - 37, and Asc = 0; 7 days: control = 0, BCG = 545 + or - 15.5, BCG + Asc = 2206 + or - 160.6, and Asc = 126 + or - 26; 14 days: control = 10 + or - 1.45, BCG = 9 + or - 1.15, BCG + Asc = 126 + or - 18, and Asc = 880 + or - 47.67 pg/ml) in the early phase of BCG infection. Low levels of NO production were detected at 2 and 7 days after BCG infection, increasing at 14 days (mean + or - SD; 2 days: control = 0, BCG = 3.7 + or - 1.59, BCG + Asc = 0.82 + or - 0.005, Asc = 0.48 + or - 0.33; 7 days: control = 0, BCG = 2.78 + or - 1.54, BCG + Asc = 3.07 + or - 1.05, Asc = 0; 14 days: control = 0, BCG = 9.05 + or - 0.53, BCG + Asc = 9.61 + or - 0.81, Asc = 10.5 + or - 0.2 (2 x 106) cells/ml). Furthermore, we also observed that Asc co-injection induced a decrease of BCG-colony-forming units (CFU) in the spleens of BCG-infected mice during the first week of infection (mean + or - SD; 2 days: BCG = 1.13 + or - 0.07 and BCG + Asc = 0.798 + or - 0.305; 7 days: BCG = 1.375 + or - 0.194 and BCG + Asc = 0.548 + or - 0.0226; 14 days: BCG = 0.473 + or - 0.184 and BCG + Asc = 0.675 + or - 0.065 (x 102) CFU). The present data suggest that Asc induces the enhancement of the immune response in the early phase of BCG infection.


Subject(s)
Animals , Female , Mice , Antigens, Helminth/pharmacology , Ascaris suum/immunology , Macrophage Activation/drug effects , Mycobacterium bovis/drug effects , Spleen/microbiology , Stem Cells/drug effects , Tuberculosis/veterinary , NADPH Dehydrogenase/metabolism , Time Factors , Tumor Necrosis Factor-alpha/biosynthesis
4.
Braz. j. med. biol. res ; 32(11): 1437-45, Nov. 1999. graf
Article in English | LILACS | ID: lil-248438

ABSTRACT

Nitric oxide (NO) is an extremely important and versatile messenger in biological systems. It has been identified as a cytotoxic factor in the immune system, presenting anti- or pro-inflammatory properties under different circumstances. In murine monocytes and macrophages, stimuli by cytokines or lipopolysaccharide (LPS) are necessary for inducing the immunologic isoform of the enzyme responsible for the high-output production of NO, nitric oxide synthase (iNOS). With respect to human cells, however, LPS seems not to stimulate NO production in the same way. Addressing this issue, we demonstrate here that peripheral blood mononuclear cells (PBMC) obtained from schistosomiasis-infected patients and cultivated with parasite antigens in the in vitro granuloma (IVG) reaction produced more nitrite in the absence of LPS. Thus, LPS-induced nitrite levels are easily detectable, although lower than those detected only with antigenic stimulation. Concomitant addition of LPS and L-N-arginine methyl ester (L-NAME) restored the ability to produce detectable levels of nitrite, which had been lost with L-NAME treatment. In addition, LPS caused a mild decrease of the IVG reaction and its association with L-NAME was responsible for reversal of the L-NAME-exacerbating effect on the IVG reaction. These results show that LPS alone is not as good an NO inducer in human cells as it is in rodent cells or cell lines. Moreover, they provide evidence for interactions between LPS and NO inhibitors that require further investigation.


Subject(s)
Humans , Antigens, Helminth/pharmacology , Blood Cells/metabolism , Granuloma/immunology , In Vitro Techniques , Lipopolysaccharides/pharmacology , Nitric Oxide/biosynthesis , Schistosoma mansoni/immunology , Schistosomiasis/immunology , Enzyme Inhibitors/pharmacology , NG-Nitroarginine Methyl Ester/pharmacology , Nitric Oxide/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL